全文获取类型
收费全文 | 49791篇 |
免费 | 2277篇 |
国内免费 | 391篇 |
专业分类
耳鼻咽喉 | 641篇 |
儿科学 | 902篇 |
妇产科学 | 636篇 |
基础医学 | 7942篇 |
口腔科学 | 818篇 |
临床医学 | 3746篇 |
内科学 | 9522篇 |
皮肤病学 | 990篇 |
神经病学 | 4201篇 |
特种医学 | 2326篇 |
外科学 | 6790篇 |
综合类 | 1955篇 |
一般理论 | 34篇 |
预防医学 | 2384篇 |
眼科学 | 905篇 |
药学 | 4378篇 |
28篇 | |
中国医学 | 359篇 |
肿瘤学 | 3902篇 |
出版年
2023年 | 354篇 |
2022年 | 924篇 |
2021年 | 1748篇 |
2020年 | 1028篇 |
2019年 | 1498篇 |
2018年 | 2178篇 |
2017年 | 1474篇 |
2016年 | 2167篇 |
2015年 | 2474篇 |
2014年 | 2799篇 |
2013年 | 3513篇 |
2012年 | 3704篇 |
2011年 | 2987篇 |
2010年 | 2644篇 |
2009年 | 2071篇 |
2008年 | 2379篇 |
2007年 | 2234篇 |
2006年 | 2034篇 |
2005年 | 1906篇 |
2004年 | 1631篇 |
2003年 | 1273篇 |
2002年 | 1106篇 |
2001年 | 826篇 |
2000年 | 868篇 |
1999年 | 751篇 |
1998年 | 421篇 |
1997年 | 319篇 |
1996年 | 275篇 |
1995年 | 206篇 |
1994年 | 188篇 |
1993年 | 172篇 |
1992年 | 349篇 |
1991年 | 308篇 |
1990年 | 301篇 |
1989年 | 292篇 |
1988年 | 290篇 |
1987年 | 255篇 |
1986年 | 214篇 |
1985年 | 190篇 |
1984年 | 163篇 |
1983年 | 123篇 |
1982年 | 107篇 |
1981年 | 69篇 |
1980年 | 73篇 |
1979年 | 118篇 |
1978年 | 76篇 |
1976年 | 72篇 |
1971年 | 73篇 |
1970年 | 73篇 |
1968年 | 89篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
7.
Hui-Ju Ch’ang 《World journal of hepatology》2015,7(16):2029-2040
The success of sorafenib in prolonging survival of patients with hepatocellular carcinoma (HCC) makes therapeutic inhibition of angiogenesis a component of treatment for HCC. To enhance therapeutic efficacy, overcome drug resistance and reduce toxicity, combination of antiangiogenic agents with chemotherapy, radiotherapy or other targeted agents were evaluated. Nevertheless, the use of antiangiogenic therapy remains suboptimal regarding dosage, schedule and duration of therapy. The issue is further complicated by combination antiangiogenesis to other cytotoxic or biologic agents. There is no way to determine which patients are most likely respond to a given form of antiangiogenic therapy. Activation of alternative pathways associated with disease progression in patients undergoing antiangiogenic therapy has also been recognized. There is increasing importance in identifying, validating and standardizing potential response biomarkers for antiangiogenesis therapy for HCC patients. In this review, biomarkers for antiangiogenesis therapy including systemic, circulating, tissue and imaging ones are summarized. The strength and deficit of circulating and imaging biomarkers were further demonstrated by a series of studies in HCC patients receiving radiotherapy with or without thalidomide. 相似文献
8.
Maxime Lafond Shin Yoshizawa Shin‐ichiro Umemura 《Journal of ultrasound in medicine》2019,38(3):567-580
Sonodynamic therapy (SDT) consists of the synergetic interaction between ultrasound and a chemical agent. In SDT, the cytotoxicity is triggered by ultrasonic stimuli, notably through cavitation. The unique features of SDT are relevant in the clinical context more than ever: the need for efficacy, accuracy, and safety while being noninvasive and preserving the patient's quality of life. However, despite the promising results of this technique, only a few clinical reports describe the use of SDT. The objective of this article is to provide an extensive overview of the clinical and preclinical research conducted in vivo on SDT, to identify the limitations, and to detail the developed strategies to overcome them. 相似文献
9.
10.
Cheong-Il Shin Sang Joon Park Ji-Hyun Kim Yeonyee Elizabeth Yoon Eun-Ah Park Bon-Kwon Koo Whal Lee 《Korean journal of radiology》2021,22(5):688
ObjectiveTo compare the lumen parameters measured by the location-adaptive threshold method (LATM), in which the inter- and intra-scan attenuation variabilities of coronary computed tomographic angiography (CCTA) were corrected, and the scan-adaptive threshold method (SATM), in which only the inter-scan variability was corrected, with the reference standard measurement by intravascular ultrasonography (IVUS).Materials and MethodsThe Hounsfield unit (HU) values of whole voxels and the centerline in each of the cross-sections of the 22 target coronary artery segments were obtained from 15 patients between March 2009 and June 2010, in addition to the corresponding voxel size. Lumen volume was calculated mathematically as the voxel volume multiplied by the number of voxels with HU within a given range, defined as the lumen for each method, and compared with the IVUS-derived reference standard. Subgroup analysis of the lumen area was performed to investigate the effect of lumen size on the studied methods. Bland-Altman plots were used to evaluate the agreement between the measurements.ResultsLumen volumes measured by SATM was significantly smaller than that measured by IVUS (mean difference, 14.6 mm3; 95% confidence interval [CI], 4.9–24.3 mm3); the lumen volumes measured by LATM and IVUS were not significantly different (mean difference, −0.7 mm3; 95% CI, −9.1–7.7 mm3). The lumen area measured by SATM was significantly smaller than that measured by LATM in the smaller lumen area group (mean of difference, 1.07 mm2; 95% CI, 0.89–1.25 mm2) but not in the larger lumen area group (mean of difference, −0.07 mm2; 95% CI, −0.22–0.08 mm2). In the smaller lumen group, the mean difference was lower in the Bland-Altman plot of IVUS and LATM (0.46 mm2; 95% CI, 0.27–0.65 mm2) than in that of IVUS and SATM (1.53 mm2; 95% CI, 1.27–1.79 mm2).ConclusionSATM underestimated the lumen parameters for computed lumen segmentation in CCTA, and this may be overcome by using LATM. 相似文献